Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Helius Medical Technologies (HSDT)
NASDAQ:HSDT
RESEARCH TOOLSreports
Holding HSDT?
Track your performance easily
HSDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.37 - $9.50
Previous Close$0.91
Volume122.25M
Average Volume (3M)2.26M
Market Cap
$1.79M
Enterprise Value-$1.69M
Total Cash (Recent Filing)$3.50M
Total Debt (Recent Filing)$23.00K
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Mar 13, 2025EPS Estimate
-$0.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.18
Shares Outstanding3,728,172
10 Day Avg. Volume85,172
30 Day Avg. Volume2,261,125
Standard Deviation0.27
R-Squared0.11
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)0.89
Price to Sales (P/S)6.76
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.30
Enterprise Value/Gross Profit-27.66
Enterprise Value/Ebitda0.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Helius Medical Technologies News
PremiumCompany Announcements
Helius Medical Technologies Reports Q3 2024 Earnings
PremiumCompany Announcements
Helius Medical Explores Strategic Alternatives Amid Challenges
Bulls Say, Bears Say
Bulls Say
Financial HealthHSDT had cash and cash equivalents of $6.4M and no debt.
Insurance ReimbursementThe company announced the first third-party reimbursement for its PoNS device from a major insurance carrier.
Regulatory ApprovalThe company's PoNS device was approved for inclusion on Lovell Government Services’ Veterans Affairs Federal Supply Schedule and General Services Administration Advantage contracts.
Bears Say
Financial PerformanceUnfavorable reimbursement decision from CMS for 2025 has led to lowering 2025 and out-year estimates.
Market CompetitionThe significant pricing disparity between CMS reimbursement rates and the prices secured through the VA Federal Supply Schedule is a major concern.
Revenue ProjectionsLower CMS pricing reduces revenue projections and limits pricing power in broader market adoption.
---
Ownership Overview
10.43%
Insiders
0.72% Mutual Funds
<0.01% Other Institutional Investors
88.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HSDT FAQ
What was Helius Medical Technologies’s price range in the past 12 months?
Helius Medical Technologies lowest stock price was $0.37 and its highest was $9.50 in the past 12 months.
What is Helius Medical Technologies’s market cap?
Currently, no data Available
When is Helius Medical Technologies’s upcoming earnings report date?
Helius Medical Technologies’s upcoming earnings report date is Mar 13, 2025 which is in 81 days.
How were Helius Medical Technologies’s earnings last quarter?
Helius Medical Technologies released its earnings results on Nov 13, 2024. The company reported -$0.99 earnings per share for the quarter, beating the consensus estimate of -$1.06 by $0.07.
Is Helius Medical Technologies overvalued?
According to Wall Street analysts Helius Medical Technologies’s price is currently Overvalued.
Does Helius Medical Technologies pay dividends?
Helius Medical Technologies does not currently pay dividends.
What is Helius Medical Technologies’s EPS estimate?
Helius Medical Technologies’s EPS estimate is -$0.94.
How many shares outstanding does Helius Medical Technologies have?
Helius Medical Technologies has 3,728,172 shares outstanding.
What happened to Helius Medical Technologies’s price movement after its last earnings report?
Helius Medical Technologies reported an EPS of -$0.99 in its last earnings report, beating expectations of -$1.06. Following the earnings report the stock price went up 1.818%.
Which hedge fund is a major shareholder of Helius Medical Technologies?
Currently, no hedge funds are holding shares in HSDT
---
Helius Medical Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.83%
12-Months-Change
Fundamentals
Return on Equity
-259.79%
Trailing 12-Months
Asset Growth
-36.92%
Trailing 12-Months
Company Description
Helius Medical Technologies
Helius Medical Technologies, Inc. operates as a medical technology company, which engages in the development of products for the treatment of neurological symptoms caused by disease and trauma. It focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. The company was founded in 2014 and is headquartered in Newtown, PA.
---
HSDT Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented several significant achievements, particularly in terms of partnerships, insurance reimbursements, and progress toward stroke authorization. However, it also highlighted a decrease in revenue year-over-year and a flat operating loss, suggesting financial challenges. Despite these lowlights, the positive developments in market access and potential revenue growth indicate a cautiously optimistic outlook.Read More>---
HSDT Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering HSDT
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-86.20%
reiterated a buy rating 10 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.20% per trade.
---